First-in-Human Experience of Using a Universal Steerable Sheath in Implanting Left Atrial Appendage Closure Devices
暂无分享,去创建一个
Sheng-Nan Chang | Hsiao-Liang Cheng | Ting‐Tse Lin | Chin-Feng Tsai | F. Chiu | Yi-Chih Wang | J. Chen | Pang-shuo Huang | Chia-Ti Tsai
[1] J. Brachmann,et al. First‐in‐human experience of left atrial appendage occlusion with the steerable FuStar sheath , 2018, Journal of interventional cardiology.
[2] L. Lai,et al. C‐reactive protein gene polymorphism predicts the risk of thromboembolic stroke in patients with atrial fibrillation: a more than 10‐year prospective follow‐up study , 2017, Journal of thrombosis and haemostasis : JTH.
[3] A. Rabinstein. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial , 2010 .
[4] Maurice Buchbinder,et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial , 2009, The Lancet.